Boule Diagnostics AB (publ) (STO:BOUL)
Sweden · Delayed Price · Currency is SEK 6.54
+0.16 (2.51%)
Nov 3, 2025, 2:42 PM CET
Boule Diagnostics AB Revenue
Boule Diagnostics AB had revenue of 127.20M SEK in the quarter ending September 30, 2025, a decrease of -2.45%. This brings the company's revenue in the last twelve months to 512.66M, down -8.99% year-over-year. In the year 2024, Boule Diagnostics AB had annual revenue of 558.46M, down -2.25%.
Revenue (ttm)
512.66M
Revenue Growth
-8.99%
P/S Ratio
0.49
Revenue / Employee
2.56M
Employees
200
Market Cap
251.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 558.46M | -12.87M | -2.25% |
| Dec 31, 2023 | 571.33M | 23.24M | 4.24% |
| Dec 31, 2022 | 548.09M | 84.74M | 18.29% |
| Dec 31, 2021 | 463.34M | 62.89M | 15.70% |
| Dec 31, 2020 | 400.46M | -98.46M | -19.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.22B |
| Elekta AB | 17.84B |
| Asker Healthcare Group AB | 15.88B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |
Boule Diagnostics AB News
- 3 months ago - Boule Diagnostics AB (OSTO:BOUL) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... - GuruFocus
- 9 months ago - Q4 2024 Boule Diagnostics AB Earnings Call Transcript - GuruFocus
- 1 year ago - Q3 2024 Boule Diagnostics AB Earnings Call Transcript - GuruFocus